Gilead wins a legal case over an HIV medicine; Eli Lilly plans to expand access to retatrutide; the piece previews three biotech updates.
Legal challenge by transgender federal employees over revoked health coverage, with notes on expanded retatrutide access and projected measles outbreak costs.